Background: To those patients with advanced lung cancer, the ultimate objective is to improve the quality of life, and lung function is an important factor affecting quality of life. We detect lung function of patient...Background: To those patients with advanced lung cancer, the ultimate objective is to improve the quality of life, and lung function is an important factor affecting quality of life. We detect lung function of patients with lung cancer and study the correlation between lung function and the patients’ survival time, to provide reference for evaluation of disease progression and prognosis. Methods: Lung function was detected on 59 cases of lung cancer and 63 normal controls. The relationship between lung function indexes and survival time was analyzed. Results: There was significant difference in ventilation function and diffusing capacity between lung cancer group and control group. Vital capacity (VC), Forced expiratory volume in one second (FEV1), Forced vital capacity (FVC), peak expiratory flow (PEF), peak expiratory flow% (PEF%), Maximal ventilatory volume (MVV) were positively correlated to survival time in patients with advanced lung cancer (r = 0.28522064, 0.28053851, 0.28289252, 0.26908133, 0.26335034, 0.28409036, P 0.05), residual volume/total lung capacity was negatively correlated to survival time (r = ?0.30760097, P 0.05). Conclusions: The lung function decrease in the patients with lung cancer. Vital capacity (VC), Forced expiratory volume in one second (FEV1), Forced vital capacity (FVC), peak expiratory flow (PEF), peak expiratory flow% (PEF%), Maximal ventilatory volume (MVV), and residual volume/total lung capacity are correlated to survival time in patients with advanced lung cancer. The lung function indexes are important marker of prognosis of patients with lung cancer.展开更多
OBJECTIVE: To observe the effects of Suhuang Zhike Capsule on pulmonary function, blood gas analysis index, serum PCT and CRP expression in patients with acute exacerbation of chronic obstructive pulmonary disease. ME...OBJECTIVE: To observe the effects of Suhuang Zhike Capsule on pulmonary function, blood gas analysis index, serum PCT and CRP expression in patients with acute exacerbation of chronic obstructive pulmonary disease. METHODS: A total of 88 patients with acute exacerbation of chronic obstructive pulmonary disease admitted to the Department of Respiratory Medicine, Xuancheng People's Hospital of Anhui Province from December 2014 to December 2016 were randomly divided into the observation group and the control group, with 44 cases in each group. The control group was given routine clinical treatment, and the observation group was given Suhuang Zhike Capsule on the basis of the treatment method of the control group. After 7 days' treatment, the improvement of lung function indexes were observed and evaluated before and after treatment(forced expiratory volume in one second(FEV_1), forced expiratory volume occupancy in the 1^(st) second percentage of vital capacity(FEVl/FVC), peak expiatory flow(PEF)), blood gas analysis index(Arterial oxygen partial pressure(PaO_2) and arterial blood carbon dioxide partial pressure(PaCO_2), oxygenation index(OI)) and serum cytokine levels(procalcitonin(PCT) and C reactive protein(CRP). RESULTS: The total effective rate of the observation group was significantly higher than that of the control group(P < 0.05). The FEV_1, FEV_1/FVC and PEF in 2 groups were significantly increased after the treatment(P < 0.05), and the above lung function indexes in the observation group were significantly higher than the control group(P < 0.05). PaO_2 and OI were significantly increased after the treatment(P < 0.05), PaCO_2 was significantly decreased after the treatment(P < 0.05), and the improvement of above blood gas analysis indexes were significantly superior of the observation group than the control group(P < 0.05). The serum PCT and CRP levels in 2 groups were significantly decreased after the treatment(P < 0.05), and the improvement in the observation group were more significant than that in the control group(P < 0.05). CONCLUSION: Suhuang Zhike Capsule can inhibit serum inflammatory cytokine levels in patients with acute exacerbation of chronic obstructive pulmonary disease, improve blood gas analysis indicators, and improve lung functions.展开更多
目的:探讨复方异丙托溴铵联合左沙丁胺醇雾化治疗COPD患者的效果。方法:回顾性收集2021年1月至2023年12月期间本院收治的106例COPD患者的临床资料,根据治疗方案的不同分为对照组52例及观察组54例,对照组采用左沙丁胺醇雾化1mL吸入治疗(2...目的:探讨复方异丙托溴铵联合左沙丁胺醇雾化治疗COPD患者的效果。方法:回顾性收集2021年1月至2023年12月期间本院收治的106例COPD患者的临床资料,根据治疗方案的不同分为对照组52例及观察组54例,对照组采用左沙丁胺醇雾化1mL吸入治疗(2次·d^(-1)),观察组在此基础上联合复方异丙托溴铵2 mL雾化吸入。分别于治疗第1、2、4和7 d天采用呼吸困难评分(Modified medical research council,MMRC)评估呼吸困难症状,治疗2 w后采用肺功能检测仪检测肺功能,包括第一秒用力呼气容积(Forced expiratory Volume in the first second,FEV1)、用力肺活量(Forced vital capacity,FVC)以及FEV1/FVC,采用血气电解质分析仪检测动脉血气,如二氧化碳分压(Partial pressure of carbon dioxide,PaCO_(2))、动脉血氧分压(Arterial partial pressure of oxygen,PaO_(2)),同时统计治疗期间不良反应情况。结果:治疗后第2、4和7 d,观察组MMRC评分均显著低于对照组(P<0.05)。治疗后,观察组FEV1/FVC、FEV1指标值均显著高于对照组(P<0.05)。治疗后,观察组PaO_(2)显著高于对照组(P<0.05);PaCO_(2)显著低于对照组(P<0.05)。两组的不良反应发生率无显著差异(P>0.05)。结论:雾化治疗联合复方异丙托溴铵治疗COPD患者,能显著提升肺功能,减轻呼吸困难症状,改善动脉血气指标,且安全性较高。展开更多
近年来,血浆致动脉硬化指数(atherogenic index of plasma,AIP)已被广泛应用于评估人体动脉硬化及相关疾病的风险。本文综述了AIP与哮喘患者肺功能之间的关系,深入探讨了哮喘患者血脂代谢的特点,并分析了AIP与血脂水平之间的内在联系。...近年来,血浆致动脉硬化指数(atherogenic index of plasma,AIP)已被广泛应用于评估人体动脉硬化及相关疾病的风险。本文综述了AIP与哮喘患者肺功能之间的关系,深入探讨了哮喘患者血脂代谢的特点,并分析了AIP与血脂水平之间的内在联系。从细胞和分子层面,本研究揭示了AIP在哮喘病理机制中的重要作用。此外,本文还阐明了AIP异常与哮喘患者肺功能损伤之间的紧密关系。本研究旨在为哮喘的诊疗提供新的视角,并评估AIP在哮喘中的潜在应用价值。展开更多
文摘Background: To those patients with advanced lung cancer, the ultimate objective is to improve the quality of life, and lung function is an important factor affecting quality of life. We detect lung function of patients with lung cancer and study the correlation between lung function and the patients’ survival time, to provide reference for evaluation of disease progression and prognosis. Methods: Lung function was detected on 59 cases of lung cancer and 63 normal controls. The relationship between lung function indexes and survival time was analyzed. Results: There was significant difference in ventilation function and diffusing capacity between lung cancer group and control group. Vital capacity (VC), Forced expiratory volume in one second (FEV1), Forced vital capacity (FVC), peak expiratory flow (PEF), peak expiratory flow% (PEF%), Maximal ventilatory volume (MVV) were positively correlated to survival time in patients with advanced lung cancer (r = 0.28522064, 0.28053851, 0.28289252, 0.26908133, 0.26335034, 0.28409036, P 0.05), residual volume/total lung capacity was negatively correlated to survival time (r = ?0.30760097, P 0.05). Conclusions: The lung function decrease in the patients with lung cancer. Vital capacity (VC), Forced expiratory volume in one second (FEV1), Forced vital capacity (FVC), peak expiratory flow (PEF), peak expiratory flow% (PEF%), Maximal ventilatory volume (MVV), and residual volume/total lung capacity are correlated to survival time in patients with advanced lung cancer. The lung function indexes are important marker of prognosis of patients with lung cancer.
文摘OBJECTIVE: To observe the effects of Suhuang Zhike Capsule on pulmonary function, blood gas analysis index, serum PCT and CRP expression in patients with acute exacerbation of chronic obstructive pulmonary disease. METHODS: A total of 88 patients with acute exacerbation of chronic obstructive pulmonary disease admitted to the Department of Respiratory Medicine, Xuancheng People's Hospital of Anhui Province from December 2014 to December 2016 were randomly divided into the observation group and the control group, with 44 cases in each group. The control group was given routine clinical treatment, and the observation group was given Suhuang Zhike Capsule on the basis of the treatment method of the control group. After 7 days' treatment, the improvement of lung function indexes were observed and evaluated before and after treatment(forced expiratory volume in one second(FEV_1), forced expiratory volume occupancy in the 1^(st) second percentage of vital capacity(FEVl/FVC), peak expiatory flow(PEF)), blood gas analysis index(Arterial oxygen partial pressure(PaO_2) and arterial blood carbon dioxide partial pressure(PaCO_2), oxygenation index(OI)) and serum cytokine levels(procalcitonin(PCT) and C reactive protein(CRP). RESULTS: The total effective rate of the observation group was significantly higher than that of the control group(P < 0.05). The FEV_1, FEV_1/FVC and PEF in 2 groups were significantly increased after the treatment(P < 0.05), and the above lung function indexes in the observation group were significantly higher than the control group(P < 0.05). PaO_2 and OI were significantly increased after the treatment(P < 0.05), PaCO_2 was significantly decreased after the treatment(P < 0.05), and the improvement of above blood gas analysis indexes were significantly superior of the observation group than the control group(P < 0.05). The serum PCT and CRP levels in 2 groups were significantly decreased after the treatment(P < 0.05), and the improvement in the observation group were more significant than that in the control group(P < 0.05). CONCLUSION: Suhuang Zhike Capsule can inhibit serum inflammatory cytokine levels in patients with acute exacerbation of chronic obstructive pulmonary disease, improve blood gas analysis indicators, and improve lung functions.
文摘目的:探讨复方异丙托溴铵联合左沙丁胺醇雾化治疗COPD患者的效果。方法:回顾性收集2021年1月至2023年12月期间本院收治的106例COPD患者的临床资料,根据治疗方案的不同分为对照组52例及观察组54例,对照组采用左沙丁胺醇雾化1mL吸入治疗(2次·d^(-1)),观察组在此基础上联合复方异丙托溴铵2 mL雾化吸入。分别于治疗第1、2、4和7 d天采用呼吸困难评分(Modified medical research council,MMRC)评估呼吸困难症状,治疗2 w后采用肺功能检测仪检测肺功能,包括第一秒用力呼气容积(Forced expiratory Volume in the first second,FEV1)、用力肺活量(Forced vital capacity,FVC)以及FEV1/FVC,采用血气电解质分析仪检测动脉血气,如二氧化碳分压(Partial pressure of carbon dioxide,PaCO_(2))、动脉血氧分压(Arterial partial pressure of oxygen,PaO_(2)),同时统计治疗期间不良反应情况。结果:治疗后第2、4和7 d,观察组MMRC评分均显著低于对照组(P<0.05)。治疗后,观察组FEV1/FVC、FEV1指标值均显著高于对照组(P<0.05)。治疗后,观察组PaO_(2)显著高于对照组(P<0.05);PaCO_(2)显著低于对照组(P<0.05)。两组的不良反应发生率无显著差异(P>0.05)。结论:雾化治疗联合复方异丙托溴铵治疗COPD患者,能显著提升肺功能,减轻呼吸困难症状,改善动脉血气指标,且安全性较高。
文摘近年来,血浆致动脉硬化指数(atherogenic index of plasma,AIP)已被广泛应用于评估人体动脉硬化及相关疾病的风险。本文综述了AIP与哮喘患者肺功能之间的关系,深入探讨了哮喘患者血脂代谢的特点,并分析了AIP与血脂水平之间的内在联系。从细胞和分子层面,本研究揭示了AIP在哮喘病理机制中的重要作用。此外,本文还阐明了AIP异常与哮喘患者肺功能损伤之间的紧密关系。本研究旨在为哮喘的诊疗提供新的视角,并评估AIP在哮喘中的潜在应用价值。
